Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

24.90 -0.09 (-0.36%)

Official Closing Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Why Pfizer's Post-COVID Future Looks Brighter Than Ever ↗

September 28, 2025

A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

Via The Motley Fool

BridgeBio, Up 80% This Year, Just Unveiled Promising News For Its Pfizer Rival ↗

September 28, 2025

The company ran an exploratory analysis of its drug, Attruby, in patients with cardiomyopathy due to TTR amyloidosis.

Via Investor's Business Daily

Down 55%, Should You Buy the Dip on Pfizer? ↗

September 28, 2025

Pfizer is facing a patent cliff and has a high payout ratio, but it is taking steps to get back on track.

Via The Motley Fool

Topics Intellectual Property

5 Dividend Powerhouses to Buy and Never Sell ↗

September 28, 2025

These blue-chip giants have paid shareholders through wars, recessions, and pandemics.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers

September 27, 2025

In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...

Via MarketMinute

Topics Economy Intellectual Property

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

September 27, 2025

Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising...

Via MarketMinute

Topics Economy Intellectual Property

US Government Braces for Unprecedented Shutdown: Economic Fallout Looms as Deadline Nears

September 27, 2025

As the clock ticks towards midnight on September 30, 2025, the United States government stands on the precipice of a highly imminent and seemingly unavoidable shutdown. With just days left until the...

Via MarketMinute

Topics Economy Government Workforce

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? ↗

September 27, 2025

The company continues to improve its pipeline.

Via The Motley Fool

3 Magnificent Stocks Under $100 to Buy Right Now ↗

September 27, 2025

You won't need a huge amount of cash to invest in these great pharma stocks.

Via The Motley Fool

Pfizer is Locking in New Growth Through a New Acquisition ↗

September 26, 2025

Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.

Via MarketBeat

Topics Artificial Intelligence

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims ↗

September 26, 2025

Pfizer Inc.

Via Benzinga

Trump's 100% Drug Tariffs 'A Meaningful Commercial Hit' For Americans, But 'Loopholes' Could Blunt Impact, Says Analyst ↗

September 26, 2025

President Donald Trump‘s proposed 100% tariffs on pharmaceuticals could have a smaller impact than initially expected, thanks to certain loopholes. However, the pharmaceutical industry, particularly...

Via Benzinga

Topics Government World Trade

Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock? ↗

September 26, 2025

The pharmaceutical giant is again plunging headfirst into weight-loss drug development.

Via The Motley Fool

Topics Intellectual Property

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

2 Top Passive Income Stocks to Buy Now ↗

September 26, 2025

These dividend stocks offer high yields and growth catalysts that could support payouts for decades.

Via The Motley Fool

Topics Bonds Economy Lawsuit

3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now ↗

September 26, 2025

These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples.

Via The Motley Fool

Topics World Trade

2 Oversold Stocks Primed to Rebound and 1 Facing Challenges

September 26, 2025

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling...

Via StockStory

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗

September 26, 2025

Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.

Via Benzinga

Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio

September 25, 2025

From Levin Papantonio

Via Business Wire

Most active S&P500 stocks in Thursday's session ↗

September 25, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Does This Acquisition Make Pfizer Stock a Great Buy? ↗

September 25, 2025

There's an opportunity to get in on the weight-loss drug craze at a reasonable price.

Via The Motley Fool

Topics Death Intellectual Property

Pfizer Tries To Fatten Its Profits With Weight Loss Drugs ↗

September 25, 2025

Pfizer needs to fortify its future revenues.

Via Talk Markets

Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025

September 25, 2025

From Pfizer Inc.

Via Business Wire

3 Top Dividend Stocks to Buy and Hold Forever ↗

September 25, 2025

These blue chip dividend stocks offer both income and growth potential.

Via The Motley Fool

Topics Intellectual Property

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. ↗

September 25, 2025

Investors once speculated that Pfizer might consider acquiring Viking.

Via The Motley Fool

Healthcare Sector Grapples with 5% Slump in 2025: A Deep Dive into Market Underperformance

September 24, 2025

The healthcare sector finds itself in turbulent waters in 2025, registering a concerning 5% slump and significantly lagging the overall S&P 500 index. This downturn marks a continuation of a multi-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

What's Driving the Market Sentiment Around Pfizer? ↗

September 24, 2025

Via Benzinga

Why Cidara Therapeutics, Already Up 173% This Year, Just Hit A Five-Year High ↗

September 24, 2025

The company is accelerating plans to run Phase 3 testing of its non-vaccine flu prevention drug by six months.

Via Investor's Business Daily

Topics Intellectual Property

The Smartest Dividend Stock to Buy With $1,000 Right Now ↗

September 24, 2025

Drug makers are out of favor right now, but the industry will survive. Here's one company that stands out as an investment option.

Via The Motley Fool

Topics Intellectual Property

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? ↗

September 24, 2025

Pfizer has a huge yield right now, but it might make more sense for dividend investors to step down in yield to these two alternatives.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.